Microbot Medical Inc
NASDAQ:MBOT

Watchlist Manager
Microbot Medical Inc Logo
Microbot Medical Inc
NASDAQ:MBOT
Watchlist
Price: 2.5 USD -0.79% Market Closed
Market Cap: $167.9m

Microbot Medical Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Microbot Medical Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Microbot Medical Inc
NASDAQ:MBOT
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other
-$186m
CAGR 3-Years
26%
CAGR 5-Years
2%
CAGR 10-Years
2%
Edwards Lifesciences Corp
NYSE:EW
Other
-$237.5m
CAGR 3-Years
-304%
CAGR 5-Years
-188%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Other
-$182m
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-14%
Abbott Laboratories
NYSE:ABT
Other
-$82m
CAGR 3-Years
N/A
CAGR 5-Years
-49%
CAGR 10-Years
-17%
Intuitive Surgical Inc
NASDAQ:ISRG
Other
-$419.1m
CAGR 3-Years
-28%
CAGR 5-Years
-10%
CAGR 10-Years
-37%
No Stocks Found

Microbot Medical Inc
Glance View

Market Cap
167.9m USD
Industry
Health Care

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 17 full-time employees. The company specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include ViRob, TipCAT, LIBERTY and certain CardioSert assets. The ViRob is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The TipCAT is a disposable self-propelled locomotive device that is specially designed to advance tubular anatomy. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature. The company is developing Self-Cleaning Shunt (SCSTM), for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) using ViRob platform. The company is developing the fully disposable robot for various endovascular interventional procedures using LIBERTY and CardioSert platforms. The company is also focused on the development of a multi generation pipeline portfolio.

MBOT Intrinsic Value
0.24 USD
Overvaluation 91%
Intrinsic Value
Price

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett